SecSonar.com

Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Eton Pharmaceuticals, Inc. (ETON) is a Biotechnology company based in US with a market capitalization of $834.6M. Revenue grew 104.9% year-over-year and the company generated $10.2M in free cash flow. This page tracks ETON's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 31 employees · IPO Nov 13, 2018

Valuation

Valuation & price

$30.26 · as of May 17, 2026 · -19.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

31.91

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$37.50$25.73$13.95Jul 25Dec 25Jul 26Jul 7, 25$14.39Jul 9, 25$15.77Jul 11, 25$14.49Jul 15, 25$14.43Jul 17, 25$13.95Jul 21, 25$14.40Jul 23, 25$15.29Jul 25, 25$15.40Jul 29, 25$14.43Jul 31, 25$14.16Aug 4, 25$14.39Aug 6, 25$15.26Aug 11, 25$17.05Aug 13, 25$17.12Aug 15, 25$17.04Aug 19, 25$16.20Aug 21, 25$17.09Aug 25, 25$17.09Aug 27, 25$17.28Aug 29, 25$17.31Sep 3, 25$17.45Sep 5, 25$17.67Sep 9, 25$17.85Sep 11, 25$17.57Sep 16, 25$17.56Sep 18, 25$18.46Sep 22, 25$18.37Sep 24, 25$19.93Sep 26, 25$21.27Sep 30, 25$21.73Oct 2, 25$19.80Oct 6, 25$20.73Oct 8, 25$20.93Oct 10, 25$19.66Oct 14, 25$18.77Oct 16, 25$18.34Oct 21, 25$18.55Oct 23, 25$18.54Oct 27, 25$18.48Oct 29, 25$18.31Oct 31, 25$18.01Nov 4, 25$18.45Nov 6, 25$19.14Nov 10, 25$16.92Nov 12, 25$17.46Nov 14, 25$16.94Nov 18, 25$17.20Nov 20, 25$16.30Nov 25, 25$16.28Nov 28, 25$16.15Dec 2, 25$15.37Dec 4, 25$16.81Dec 8, 25$16.36Dec 10, 25$16.41Dec 12, 25$16.70Dec 16, 25$15.95Dec 18, 25$16.02Dec 22, 25$16.57Dec 24, 25$16.99Dec 29, 25$16.80Jan 2, 26$16.26Jan 6, 26$16.57Jan 8, 26$16.52Jan 12, 26$15.47Jan 14, 26$15.67Jan 16, 26$15.14Jan 21, 26$15.17Jan 23, 26$14.99Jan 27, 26$15.04Jan 29, 26$15.25Feb 2, 26$15.17Feb 4, 26$14.75Feb 9, 26$14.81Feb 11, 26$16.05Feb 13, 26$17.07Feb 18, 26$17.21Feb 20, 26$17.93Feb 24, 26$18.28Feb 26, 26$17.25Mar 2, 26$18.15Mar 4, 26$17.53Mar 6, 26$16.80Mar 10, 26$17.40Mar 12, 26$19.02Mar 17, 26$18.92Mar 19, 26$20.77Mar 23, 26$23.81Mar 25, 26$23.84Mar 27, 26$23.24Mar 31, 26$24.68Apr 2, 26$24.99Apr 7, 26$25.06Apr 9, 26$27.10Apr 13, 26$26.05Apr 15, 26$26.97Apr 17, 26$25.04Apr 22, 26$23.61Apr 24, 26$23.02Apr 28, 26$24.16Apr 30, 26$24.12May 4, 26$30.16May 6, 26$30.15May 8, 26$29.65May 12, 26$29.71May 14, 26$29.96May 18, 26$32.49May 20, 26$34.45May 22, 26$32.59May 28, 26$31.86Jun 1, 26$28.68Jun 3, 26$27.61Jun 5, 26$29.13Jun 9, 26$30.53Jun 11, 26$32.11Jun 15, 26$32.15Jun 17, 26$32.76Jun 22, 26$32.72Jun 24, 26$33.98Jun 26, 26$35.70Jul 2, 26$37.50
$13.8952-week range$37.50
Loading valuation history…

Fundamentals

Key fundamentals

$834.6M

Market cap

104.9%

Revenue growth (YoY)

53.5%

Gross margin

$10.2M

Free cash flow (USD)

$5.1M

Net debt

3.9%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$0.00FY 2018$0.00FY 2019$959.0KFY 2020$39.0KFY 2021$21.8MFY 2022$21.3MFY 2023$31.6MFY 2024$39.0MFY 2025$80.0M
$0$80M

Free cash flow by year

2017 → 2025

FY 2017$-4.8MFY 2018$-8.4MFY 2019$-19.9MFY 2020$-22.4MFY 2021$-8.0MFY 2022$2.0MFY 2023$6.0MFY 2024$943.0KFY 2025$10.2M
-$4.8M$10.2M

Gross margin by year

2021 → 2025

FY 202188.0%FY 202267.4%FY 202366.6%FY 202460.0%FY 202553.5%
88.0%53.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $0.05)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 9, 2026Filing
  • 8-K eventSupply Agreement SignedMay 19, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventProduct LaunchMay 1, 2026Filing
  • 8-K eventClinical Study InitiatedApr 27, 2026Filing
  • 8-K eventCFO AppointmentApr 16, 2026Filing
  • 8-K eventCredit Agreement AmendmentApr 15, 2026Filing

Questions

Frequently asked questions

What is Eton Pharmaceuticals, Inc.'s market cap?

Eton Pharmaceuticals, Inc. (ETON) has a market capitalization of $834.6M.

What is ETON's P/E ratio?

A meaningful P/E ratio is not available for ETON — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ETON's price-to-book (P/B) ratio?

ETON trades at 31.91 times book value per share.

When did Eton Pharmaceuticals, Inc. last report earnings?

ETON last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying ETON stock?

SEC Form 4 filings show no open-market insider buys at Eton Pharmaceuticals, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

TBPH

Theravance Biopharma, Inc.

$835.7M

ZBIO

Zenas BioPharma, Inc.

$829.2M

GERN

Geron Corporation

$805.1M

PHAT

Phathom Pharmaceuticals, Inc.

$788.3M

XNCR

Xencor, Inc.

$885.3M

JANX

Janux Therapeutics, Inc.

$894.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.